1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Dapagliflozin propanediol (FORXIGA™/FARXIGA™1), Placebo comparator - AMI, STEMI | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 450 | 2023-06-12 | 2025-12-19 |
Non-ST Elevated Myocardial Infarction (1) · ST Elevation Myocardial Infarction (1) · Ventricular Dysfunction, Left (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Infarction (1) · Ischemia (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1) · Ventricular Dysfunction (1)
dapagliflozin (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)